The Marcus (MCS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Second quarter fiscal 2025 saw significant year-over-year growth in revenue, operating income, and net earnings, driven by a strong and diverse film slate in theaters and stable group bookings in hotels, despite ongoing renovations impacting some hotel operations.
Net earnings for Q2 2025 were $7.3M ($0.23 per share), reversing a net loss in Q2 2024, with all guest rooms at Hilton Milwaukee now fully renovated.
Theatres saw record Memorial Day weekend results and a 29.8% revenue increase, while hotels maintained revenue levels despite room displacement from renovations.
Financial highlights
Q2 2025 total revenues were $206.0M, up 17% year-over-year; operating income was $13.0M, up from $2.2M; net earnings reached $7.3M versus a net loss of $20.2M in Q2 2024.
Adjusted EBITDA for Q2 2025 was $32.3M, a 46.9% increase year-over-year.
First half 2025 revenues were $354.8M, up 12.8% year-over-year; Adjusted EBITDA for the first half was $32.0M, up 32%.
Cash and cash equivalents at June 30, 2025, were $14.9M; debt-to-capitalization ratio was 0.29, net leverage 1.61x.
Cash flow from operations was $31.6M, down from $36M in the prior year quarter.
Outlook and guidance
Capital expenditures for Fiscal 2025 are expected to be $70–$85M, with a step down in CapEx anticipated for 2026 as the reinvestment cycle concludes.
The company expects improved admission per cap growth in the second half of the year as new pricing strategies take effect.
Group room revenue bookings for 2025 are running slightly ahead of last year, and 2026 group pace is 20% ahead year-over-year; banquet and catering revenue pace for 2025 and 2026 is running 15–20% ahead.
Effective tax rate for fiscal 2025 is expected in the 28–32% range, excluding one-time items.
Management expects continued performance improvements in both business segments.
Latest events from The Marcus
- 2025 revenue reached $758.5M with strong theatre and hotel performance and robust growth outlook.MCS
Investor presentation5 Mar 2026 - Both divisions outperformed their industries, with strong revenue growth and a robust 2026 outlook.MCS
Q4 202526 Feb 2026 - Q2 revenue dropped 15%, but hotels outperformed and group bookings surged as theatres rebounded.MCS
Q2 20242 Feb 2026 - Record Q3 revenue, earnings, and industry outperformance with a strengthened capital structure.MCS
Q3 202417 Jan 2026 - Q4 revenue up 16.6% and record hotel results, with strong momentum for 2025 growth.MCS
Q4 202423 Dec 2025 - Shelf registration enables up to $150M in securities offerings and 5M-share secondary sales.MCS
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, incentive plan, executive pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, incentive plan, pay, and auditor ratification.MCS
Proxy Filing2 Dec 2025 - Q1 revenue up 7.4%, but net loss widened to $16.8M; strong outlook for films and hotels.MCS
Q1 202519 Nov 2025